2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: a prospective open‐label, single‐arm, phase II clinical trial

      J Clin Oncol

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          10.1200/JCO.2021.39.15_suppl.5583

          Gastroenterology & Hepatology
          Gastroenterology & Hepatology

          Comments

          Comment on this article